5α-Reductase inhibitors, Aquablation, Avanafil, Benign Prostatic Diseases, Bladder injury, Bladder outlet obstruction, Bladder trauma, BOO, BOOI, BPD, BPE, BPH, BPO, Chronic bacterial prostatitis, CP/CPPS, CPPS, Desmopressin, Detrusor, Detrusor hypocontractility, Dihydrotestosterone, Drug adherence, Drug therapy, Dutasteride, EAU, Ejaculation, Ejaculation preservation, Ejaculatory dysfunction, Endoscopic surgery, Epidemiology, Erectile dysfunction, Fexapotide triflutate, Fibrosis, Finasteride, Frequency volume chart, GL-XPS, Guidelines, Herbal medicines, Hypogonadism, Impaired contractility, Incontinence, Infertility, Inflammation, Inflammatory biomarkers, Innervation, IPP, IPSS, iTIND, Laparoscopy, Laser Bipolar, Laser prostatectomy, Laser therapy, LUT, LUTS, Major cardiac adverse event, Management of Non-Neurogenic LUTS incl. BPO, Medical therapy, Meta analysis, Meta regression, Metabolic syndrome, Microbiome, Micturition chart, Minimally invasive surgical therapy, minimally invasive techniques, Mirabegron, Monotherapies, Muscarinic antagonist, nitinol, Nocturia, Noninvasive, NX-1207, Overactive bladder, Pathogenesis, Pathophysiology, Patient satisfaction, Patient-reported outcome, Permixon, Pharmacology, Phenotypically directed multimodal management, Phosphodiesterase type 5 inhibitor, Phosphodiesterase type 5 inhibitors, Phytotherapy, Placebo effect, Prospective study, Prostate, Prostate surgery, Prostate-specific antigen, Prostatectomy, Prostatic, Prostatic artery embolization, Prostatic hyperplasia, Prostatitis, PUL, Quality of life, Randomized trial, RASP, Remission, Retrograde ejaculation, Robotic, Robotic surgery, Robotics, Serenoa repens, Sexual Dysfunction, Sexual dysfunctions, Sildenafil, Simple prostatectomy, Solifenacin, Stem cells, Surgery, Surgical intervention, Systematic review, Tadalafil, Tamsulosin, Telomerase, Testosterone, TUR syndrome, TURis, TURP, Ultrasonography, Underactive bladder, urethral implantable device, Urethral injury, Urethral trauma, Urinary Incontinence in Adults, Urinary nerve growth factor, Urinary sphincter, Urodynamics, Urolift, Vardenafil, Voiding, Voiding dysfunction, α-Adrenergic blocker, α-Adrenoceptor antagonists, α-Blocker, α-blockers, α1-Blockers